Jones Financial Companies’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.3K | Buy |
600
+253
| +73% | +$31.7K | ﹤0.01% | 2056 |
|
|
2025
Q1 | $39.3K | Buy |
347
+161
| +87% | +$18.2K | ﹤0.01% | 2158 |
|
|
2024
Q4 | $25.4K | Buy |
186
+55
| +42% | +$7.51K | ﹤0.01% | 2151 |
|
|
2024
Q3 | $15.1K | Buy |
131
+107
| +446% | +$12.3K | ﹤0.01% | 2063 |
|
|
2024
Q2 | $3.3K | Buy |
+24
| New | +$3.3K | ﹤0.01% | 2049 |
|
|
2022
Q3 | – | Sell |
-13
| Closed | -$1K | – | 666 |
|
|
2022
Q2 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 663 |
|
|
2021
Q2 | – | Sell |
-6
| Closed | -$1K | – | 742 |
|
|
2021
Q1 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 768 |
|